T62N (p.Thr62Asn) variant of RHO (Rhodopsin)

T62N (p.Thr62Asn) in RHO (Rhodopsin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes population frequency data, published literature, and structural context.

T62N (p.Thr62Asn) variant details